- Home
- Clinical Trials
- New investigational drug for patients with previously treated CLL/SLL or NHL
New investigational drug for patients with previously treated CLL/SLL or NHL
- Trial ID:
- IRB-21-7749
- Marin Xavier, MD
This study requires weekly visits for the first month, then monthly visits from the second month on.
Inclusion Criteria
Patients must:- Patients must:
- Be at least 18 years of age
- Have an ECOG score of 0-2
- Have a tumor sample available that was obtained after most recent treatment or be willing to get one
Exclusion Criteria
Patients must not:- Patients must not:
- Be on prior anticancer therapy within 4 weeks before the first dose of the investigational drug
- Have had major surgery within 4 weeks prior to planned start
- Be on warfarin
- Have tested positive for Human Immunodeficiency Virus (HIV)
Additional Info
- For more information about this clinical trial, search for NCT03740529 at www.clinicaltrials.gov
Contact Info:
- Clinical Research Services
- CRSLeadership@scrippshealth.org